ARAnna De Rosa

Anna De Rosa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Anna De Rosa has a total of 199 co-authors. Here are the top co-authors by number of shared publications:

  • Giuseppe De Michele

    Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy

    18 shared publications
  • Silvio Peluso

    Department of Neurosciences, Reproductive and Odontostomatological Sciences, "Federico II" University, Naples, Italy

    9 shared publications
  • Augusta Giglio

    Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy

    7 shared publications
  • Gianluigi Rosario Palmieri

    Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Naples, Italy

    6 shared publications
  • Francesco Saccà

    Department of Neurosciences and Reproductive and Odontostomatological Sciences, Federico II University, Via Pansini 5, 80131, Naples, Italy

    5 shared publications
  • Sabina Pappatà

    Institute of Biostructure and Bioimaging, National Council of Research, Naples, Italy

    5 shared publications

Latest Publications

  • Involuntary mouth movements associated with dementia in Parkinson’s Disease

    by Gabriele Riccio, Natascia De Lucia, Rosa Coppola, Maria Rosaria Chiariello, Augusta Giglio, Anna De Rosa

  • Top Cited Papers
    Open Access

    Quality and Readability of ChatGPT Performance on Parkinson's Disease

    by Gabriele Riccio, Rosa Coppola, Maria Rosaria Chiariello, Augusta Giglio, Anna De Rosa

    Background: Chat Generative Pre‐trained Transformer (ChatGPT) is increasingly used for medical education and healthcare counseling. Objective: To evaluate the reliability, quality, usefulness, and readability of ChatGPT‐4o responses to professional medical quizzes and patient frequently asked questions (FAQs) about Parkinson's disease (PD). Methods: Twenty‐two quizzes were put into ChatGPT‐4o and also given to two neurologists. ChatGPT answers to 20 FAQs were analyzed by three neurologists using the modified Discern score, the Global Quality score, and the Usefulness score. Text readability was assessed using the Flesch–Kincaid Reading Grade Level, the Flesch Reading Ease Score, and the Simple Measure of Gobbledygook. Results: The agreement between the neurologists and ChatGPT was fair. The answers to the FAQs were of good quality, but unreliable and difficult to read. Conclusions: ChatGPT may be an additional valid tool for professional medical education. The quality of the answers to the FAQs is good, but the text is aimed primarily at highly educated individuals. The readability and reliability of the output would likely improve by providing the chatbot with specific prompts.


  • Familial tremor linked to a heterozygous variant in the Ceruloplasmin gene

    by Gabriella De Vita, Giancarlo Blasio, Gabriele Riccio, Rosa Coppola, Domenico Dell’AVersana, Antonietta Coppola, Sirio Cocozza, Eduardo Gragnano, Marcello Esposito, Giuseppe De Michele, et al.

  • Open Access

    Sex-Independent Upregulation of miR-146a-5p in Parkinson’s Disease Patients: A Longitudinal Study

    by Annamaria Vallelunga, Tommaso Iannitti, Giovanna Dati, Julio César Morales-Medina, Marina Picillo, Marianna Amboni, Calogero Edoardo Cicero, Roberto Cilia, Rosa De Micco, Anna De Rosa, et al.

    Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor and non-motor symptoms. The absence of reliable fluid biomarkers continues to hinder early diagnosis and effective monitoring of disease progression. Circulating microRNAs (cmiRNAs) are potential candidates, given their stability in biofluids and their ability to mirror pathological processes. We conducted a longitudinal study in 30 early-stage levodopa-naive PD patients (22 men, 8 women). Serum samples were collected at baseline (T0) and at a follow-up time point two years later (T2). A panel of MicroRNAs (miRNAs) (miR-146a-5p, miR-34a-5p, miR-155-5p, miR-29a-3p, miR-106a-5p) were quantified by quantitative real-time PCR. Data were expressed as relative expression (2^−ΔCt), and statistical analyses included sex-stratified comparisons and paired tests for longitudinal changes. At baseline, no significant differences were found in the expression of the miRNAs between male and female PD patients. In contrast, longitudinal within-subject analysis revealed a highly significant upregulation in miR-146a-5p expression from T0 to T2 in both sexes (p < 0.0001). No other miRNAs in the panel exhibited significant changes over time. CmiR-146a-5p levels rise markedly over time in PD patients, independent of sex, suggesting that this miRNA could be a dynamic biomarker of disease progression.


  • Open Access

    Spectral domain and angiography optical coherence tomography in atypical parkinsonisms and Parkinson disease: an explorative study

    by Gilda Cennamo, Laura Giovanna Di Maio, Gabriele Riccio, Rosa Coppola, Luigi Baratto, Augusta Giglio, Fiore Manganelli, Giuseppe De Michele, Ciro Costagliola, Anna De Rosa


  • Prevalence and features of headache in Parkinson’s disease: the role of dopamine

    by Augusta Giglio, Cinzia Valeria Russo, Gabriele Riccio, Simone Braca, Gennaro Cretella, Antonio Stornaiuolo, Luigi Baratto, Enrico Marano, Giuseppe De Michele, Anna De Rosa

    Introduction Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra, but dopamine also plays a role in the pathophysiology of migraine. Objective The aim of this study is to assess lifetime and previous year prevalence rates of headache in PD patients compared with controls. Patients and methods We enrolled 101 patients (57 M and 44 W) and 101 controls (62 M and 39 W), comparable for age and gender, who underwent a semi-structured questionnaire to assess the occurrence and the features of headache, and Beck Depression Inventory (BDI). Results We did not find any significant differences in the overall prevalence of lifetime and last 12-month headache between the two groups, as well as lifetime and last year tension-type headache (TTH) and migraine. Patients, especially those suffering from migraine and treated with dopamine agonists (DA), more frequently showed headache remission after the onset of motor symptoms compared to the age-related remission observed in controls (p = 0.001). Patients affected by headache were less frequently treated with DA in comparison with those without (p = 0.051). Depression of mood was more severe among PD patients with migraine than with TTH (p = 0.021). PD patients with headache exhibiting the akinetic-rigid subtype more frequently reported motor fluctuations than those presenting with tremor-dominant disease (p = 0.040). Conclusions The prevalence of headache in PD follows that described in the general population, but dopaminergic pathway degeneration, loss of dopamine activation on the trigeminal-vascular system, and DA treatment might favor migraine improvement and remission in PD patients.

  • XR-Based Serious Game for Assessing Bradykinesia in Patients with Parkinson’s Disease

    by Pasquale Arpaia, Egidio De Benedetto, Anna De Rosa, Augusta Giglio, Alessandro Pepino, Gabriele Riccio, Ersilia Vallefuoco


  • Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study

    by Roberto Erro, Giulia Lazzeri, Carmen Terranova, Giulia Paparella, Angelo Fabio Gigante, Rosa De Micco, Luca Magistrelli, Francesca Di Biasio, Francesca Valentino, Vincenzo Moschella, et al.

    Background: Tremor disorders remain as clinical diagnoses and the rate of misdiagnosis between the commonest non‐parkinsonian tremors is relatively high. Objectives: To compare the clinical features of Essential Tremor without other features (pure ET), ET plus soft dystonic signs (ET + DS), and tremor combined with dystonia (TwD). Methods: We compared the clinical features of patients with pure ET, ET + DS, and TwD enrolled in The ITAlian tremor Network (TITAN). Linear regression models were performed to determine factors associated with health status and quality of life. Results: Three‐hundred‐eighty‐three patients were included. Sex distribution was significantly different between the groups with males being more represented in pure ET and females in TwD. The initial site of tremor was different between the groups with about 40% of TwD having head tremor and ET + DS unilateral upper limb tremor at onset. This pattern mirrored the distribution of overt dystonia and soft dystonic signs at examination. Sensory trick, task‐specificity, and position‐dependence were more common, but not exclusive, to TwD. Pure ET patients showed the lowest degree of alcohol responsiveness and ET + DS the highest. Midline tremor was more commonly encountered and more severe in TwD than in the other groups. Regression analyses demonstrated that tremor severity, sex, age, and to a lesser degree the variable “group”, independently predicted health status and quality of life, suggesting the existence of other determinants beyond tremor. Conclusions: Pure ET and TwD manifest with a phenotypic overlap, which calls for the identification of diagnostic biomarkers. ET + DS shared features with both syndromes, suggesting intra‐group heterogeneity.


  • Open Access

    Spectral Domain and Angiography Optical Coherence Tomography in Parkinson’s Disease: Structural And Vascular Changes in the Retina Correlate with Disease Severity and Progression

    by Laura Giovanna Di Maio, Gilda Cennamo, Daniela Montorio, Gianluigi Rosario Palmieri, Luigi Baratto, Sandra Perillo, Augusta Giglio, Alessandro Filla, Vincenzo Brescia Morra, Giuseppe De Michele, et al.

    Background . Parkinson’s disease (PD) is a common neurodegenerative disorder characterized by bradykinesia, resting tremor, and muscle rigidity. Visual disturbances have been also described among non‐motor features. Objective . We aimed to investigate the structural and vascular changes in the retinal and choroidal vascular networks, and to assess any relationship with motor and non‐motor symptoms (NMS) in PD patients. Methods . Ganglion cell complex (GCC), retinal nerve fiber layer (RNFL), and subfoveal choroidal thickness (SFCT) were examined using spectral domain‐optical coherence tomography (SD‐OCT). The vessel density (VD) of retinal and choriocapillary vascular networks in macular area and the foveal avascular zone (FAZ) area were evaluated by OCT angiography (OCTA). All patients underwent clinical evaluation using motor section of the Unified PD Rating Scale (UPDRS‐III) and the Hoehn and Yahr (HY) scale. Results . A total of 48 eyes from 24 PD patients and 50 eyes from 25 controls were assessed. At SD‐OCT, GCC and RNFL were more significantly thin in patients compared to controls. At OCTA exam, PD subjects showed lower values in VD of superficial capillary plexus (SCP) and radial peripapillary capillary plexus in comparison to controls, whereas FAZ area resulted in a significant increase in the patient group. We found a negative correlation between the age at onset and VD of SCP, and between HY score and RNFL thickness and FAZ. UPDRS‐III score was negatively correlated with VD of deep capillary plexus. Discussion . The impairment of retinal structure and microvasculature seems to correlate with disease severity and progression in PD. Retinal anomalies can be considered as non‐motor manifestations that could occur already in the early stage of the disease.


  • Motor and non-motor features in Parkinson’s Disease patients carrying GBA gene mutations

    by Gianluigi Rosario Palmieri, Chiara Pane, Enza Maria Valente, Ilaria Palmieri, Carmen Diletta Paola Dello Iacovo, Nunzia Cuomo, Augusta Giglio, Natascia De Lucia, Tommasina Fico, Sandra Perillo, et al.

    Background Mutations of the Glucocerebrosidase (GBA) gene are the most common genetic risk factor yet discovered for Parkinson’s Disease (PD), being found in about 5–14% of Caucasian patients. Objective We aimed to assess motor and non-motor symptoms (NMS) in patients with GBA-related PD (GBA-PD) in comparison with idiopathic PD (iPD) subjects using standardized and validated scales. Methods Eleven (4 M, 7 F) patients with GBA-PD and 22 iPD patients, selected from the same cohort and matched for gender, age, and disease duration, were enrolled. The disease severity was assessed by Unified Parkinson’s Disease Rating Scale—section III, gait disorder and falls by Freezing of Gait Questionnaire, and motor fluctuations by Wearing off questionnaire. NMS were evaluated using the following scales: Mini-Mental State Examination and extended neuropsychological battery, if required, Non-Motor Symptoms Scale, SCOPA-AUT Questionnaire, Apathy Evaluation Scale, Beck Depression Inventory, Epworth Sleepiness Scale, Restless Legs Syndrome Rating Scale, REM Sleep Behavior Disorder Screening Questionnaire, and Questionnaire for Impulsive–Compulsive Disorders in Parkinson’s disease. Results GBA-PD patients showed a more severe and rapidly progressive disease, and more frequent positive family history for PD, akinetic-rigid phenotype, postural instability, dementia, and psychosis in comparison to iPD. Two of three subjects carrying L444P mutation presented with early dementia. We also found a higher occurrence of fatigue, diurnal sleepiness, and intolerance to heat/cold in the carriers group. Conclusions Our results confirm that NMS and a more severe and faster disease course more frequently occur among GBA-PD patients in comparison to iPD.